Psychotropic Medication and GDR Support for Nursing Homes (F605, formerly F758)

What changed

On April 28, 2025, CMS began surveying unnecessary psychotropic medication use under F605 (Chemical Restraints / Unnecessary Psychotropic Medications). The former F758 guidance was folded into F605, and F757 now covers non-psychotropic unnecessary drugs only. CMS also expanded the "convenience" concept to include medication use that causes sedation or reduces the effort staff need to meet a resident's needs, and emphasized the resident's right to be informed and to accept or decline a psychotropic medication before it is started or increased.

Source: CMS QSO-25-14-NH (revised March 10, 2025), cms.gov

What surveyors look for (summary of 42 CFR 483.45(e))

  • A diagnosed, documented condition for every psychotropic medication

  • Gradual dose reductions and behavioral interventions, unless clinically contraindicated

  • PRN psychotropic orders limited to 14 days unless the prescriber documents a rationale and duration

  • PRN antipsychotic orders limited to 14 days and not renewed without a prescriber evaluation

This page is educational and is not legal or regulatory advice.

How US Psychiatry PLLC helps

  • Psychotropic review: a board-certified psychiatrist or PMHNP reviews residents on psychotropic medications for indication, dose, duration, and monitoring.

  • GDR plans: documented reduction attempts with dates, outcomes, and next steps, or a clear clinical contraindication.

  • PRN clean-up: evaluation and documentation for PRN psychotropic and antipsychotic orders approaching 14 days.

  • Informed-participation documentation: notes that reflect resident or representative discussions.

  • IDT and QAPI support: participation in behavior meetings and psychotropic committees.

  • Staff education: non-pharmacological approaches for dementia-related distress.

Ways to work with us

  • Psychotropic & GDR review — one-time review of residents on psychotropics with a written summary for your team

  • Ongoing coverage — GDR tracking built into regular psychiatric rounds

  • Pre-survey consult — focused review ahead of your survey window

No published rates. Request a proposal below.

F605 Psychotropic & GDR Readiness Checklist

For each resident on a psychotropic medication:

  • Diagnosis and specific target symptoms documented

  • Non-pharmacological interventions tried and documented

  • Resident/representative informed and given the chance to accept or decline before start or increase

  • GDR attempted within required timeframes, with date, outcome, and plan; or clinical contraindication documented by the prescriber

  • PRN psychotropic orders ≤14 days, or rationale and duration documented

  • PRN antipsychotic orders ≤14 days; renewals only after prescriber evaluation

  • Monitoring for side effects (sedation, falls, metabolic, movement) documented

  • Pharmacist MRR recommendations addressed

  • Behavior monitoring data reviewed in IDT / psychotropic committee

Educational only. Source: CMS State Operations Manual Appendix PP, F605 (Rev. 229, eff. April 28, 2025).